Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,251
datasets available to search
ShareScore release 0.9.0
Dataset results
3,251 results for “ovarian cancer”
Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer
ClinicalTrials.gov study NCT03364673. IPD Sharing: NO. Countries: 1. Publications: 1.
Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
ClinicalTrials.gov study NCT00436215. IPD Sharing: NO. Countries: 1. Publications: 4.
Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab
ClinicalTrials.gov study NCT00194714. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00806156. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00445549. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer
ClinicalTrials.gov study NCT00327171. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00477386. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Eribulin Mesylate in Treating Patients With Recurrent Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00334893. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Niraparib (GSK3985771) Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy
ClinicalTrials.gov study NCT02655016. IPD Sharing: NO. Countries: 14. Publications: 11.
Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)
ClinicalTrials.gov study NCT01684878. IPD Sharing: Not stated. Countries: 10. Publications: 1.
A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer
ClinicalTrials.gov study NCT01849874. IPD Sharing: YES. Countries: 19. Publications: 2.
Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02431559. IPD Sharing: NO. Countries: 2. Publications: 1.
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
ClinicalTrials.gov study NCT01091428. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00262847. IPD Sharing: Not stated. Countries: 4. Publications: 9.
Ovarian Cancer Vaccine for Patients in Remission
ClinicalTrials.gov study NCT01068509. IPD Sharing: Not stated. Countries: 2. Publications: 10.
Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00866723. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
ClinicalTrials.gov study NCT00551070. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemcitabine Hydrochloride Alone or With M6620 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT02595892. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment
ClinicalTrials.gov study NCT02326844. IPD Sharing: NO. Countries: 1. Publications: 3.
Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT03029598. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.